# A Study to Learn About the Study Medicine (PF-08653944) in People With Obesity or Overweight and Type 2 Diabetes (T2D)

> **NCT07400653** · PHASE3 · RECRUITING · sponsor: **Pfizer** · enrollment: 999 (estimated)

## Conditions studied

- Obesity
- Overweight and/or Obesity
- Overweight
- Diabetes, Type 2
- Type 2 Diabetes

## Interventions

- **DRUG:** PF-08653944
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT07400653
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-02-24
- **Primary completion:** 2027-10-12
- **Final completion:** 2028-05-16
- **Target enrollment:** 999 (ESTIMATED)
- **Last updated:** 2026-05-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07400653

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07400653, "A Study to Learn About the Study Medicine (PF-08653944) in People With Obesity or Overweight and Type 2 Diabetes (T2D)". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT07400653. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*